We analyzed ASCL1 ChIP-Seq datasets from SCN lung and prostate cancer cell lines, as well as in LuCaP prostate cancer patient-derived xenografts (PDXs) (SI Appendix, Figs. S4–S6). Here, ASCL1 is linked to prostate carcinoma.